Prof. Dr. Scott McNeil

Hemmrich, Eva, & McNeil, Scott. (2024). Strategic aspects for the commercialization of nanomedicines [Journal-article]. Journal of Controlled Release, 369, 617–621. https://doi.org/10.1016/j.jconrel.2024.04.003

Hemmrich, Eva, & McNeil, Scott. (2023). Active ingredient vs excipient debate for nanomedicines. Nature Nanotechnology, 18, 692–695. https://doi.org/10.1038/s41565-023-01371-w

Klein, Kevin, Borchard, Gerrit, Shah, Vinod P., Flühmann, Beat, McNeil, Scott E., & de Vlieger, Jon S. B. (2021). A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways. Annals of the New York Academy of Sciences, 1502, 5–13. https://doi.org/10.1111/nyas.14662

de Vlieger, Jon S. B., Crommelin, Daan J. A., Tyner, Katherine, Drummond, Daryl C., Jiang, Wenlei, McNeil, Scott E., Neervannan, Sesha, Crist, Rachael M., & Shah, Vinod P. (2019). Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”. AAPS Journal, 21. https://doi.org/10.1208/s12248-019-0329-7

Wu, Jiewei, Crist, Rachael M., McNeil, Scott E., & Clogston, Jeffrey D. (2019). Ion quantification in liposomal drug products using high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 165, 41–46. https://doi.org/10.1016/j.jpba.2018.11.048

Cedrone, Edward, Neun, Barry W., Rodriguez, Jamie, Vermilya, Alison, Clogston, Jeffrey D., McNeil, Scott E., Barenholz, Yechezkel, Szebeni, Janos, & Dobrovolskaia, Marina A. (2018). Anticoagulants influence the performance of in vitro assays intended for characterization of nanotechnology-based formulations. Molecules, 23. https://doi.org/10.3390/molecules23010012

Swierczewska, Magdalena, Crist, Rachael M., & McNeil, Scott E. (2018). Evaluating nanomedicines: Obstacles and advancements (Vol. 1682, pp. 3–16). https://doi.org/10.1007/978-1-4939-7352-1_1

Hussaarts, Leonie, Mühlebach, Stefan, Shah, Vinod P., McNeil, Scott, Borchard, Gerrit, Flühmann, Beat, Weinstein, Vera, Neervannan, Sesha, Griffiths, Elwyn, Jiang, Wenlei, Wolff-Holz, Elena, Crommelin, Daan J. A., & de Vlieger, Jon S. B. (2017). Equivalence of complex drug products: advances in and challenges for current regulatory frameworks. Annals of the New York Academy of Sciences, 1407(1), 39–49. https://doi.org/10.1111/nyas.13347

Smith, Mackensie C, Crist, Rachael M, Clogston, Jeffrey D, & McNeil, Scott E. (2017). Zeta potential: a case study of cationic, anionic, and neutral liposomes. Analytical and Bioanalytical Chemistry, 409(24), 5779–5787. https://doi.org/10.1007/s00216-017-0527-z

Adiseshaiah, Pavan P., Crist, Rachael M., Hook, Sara S., & McNeil, Scott E. (2016). Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nature Reviews Clinical Oncology, 13, 750–765. https://doi.org/10.1038/nrclinonc.2016.119

Coelho, Sergio G., Patri, Anil K., Wokovich, Anna M., McNeil, Scott E., Howard, Paul C., & Miller, Sharon A. (2016). Repetitive application of sunscreen containing titanium dioxide nanoparticles on human skin. JAMA Dermatology, 152, 470–472. https://doi.org/10.1001/jamadermatol.2015.5944

Dobrovolskaia, Marina A., & McNeil, Scott E. (2016). Handbook of immunological properties of engineered nanomaterials: Second edition (Vol. 1-3). https://doi.org/10.1142/9677

McNeil, Scott E. (2016). Evaluation of nanomedicines: Stick to the basics. Nature Reviews Materials, 1. https://doi.org/10.1038/natrevmats.2016.73

Tinkle, Sally, McNeil, Scott E., Mühlebach, Stefan, Bawa, Raj, Borchard, Gerrit, Barenholz, Yechezkel Chezy, Tamarkin, Lawrence, & Desai, Neil. (2014). Nanomedicines: addressing the scientific and regulatory gap. Annals of the New York Academy of Sciences, 1313, 35–56. https://doi.org/10.1111/nyas.12403

Wang, Q.Q., Zhu, J.Y., Gleisner, R., Kuster, T.A., Baxa, U., & McNeil, S.E. (2012). Morphological development of cellulose fibrils of a bleached eucalyptus pulp by mechanical fibrillation. Cellulose, 19, 1631–1643. https://doi.org/10.1007/s10570-012-9745-x

Sadrieh, Nakissa, Wokovich, Anna M., Gopee, Neera V., Zheng, Jiwen, Haines, Diana, Parmiter, David, Siitonen, Paul H., Cozart, Christy R., Patri, Anil K., McNeil, Scott E., Howard, Paul C., Doub, William H., & Buhse, Lucinda F. (2010). Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO 2 particles. Toxicological Sciences, 115, 156–166. https://doi.org/10.1093/toxsci/kfq041

Aggarwal, Parag, Hall, Jennifer B., McLeland, Christopher B., Dobrovolskaia, Marina A., & McNeil, Scott E. (2009). Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Advanced Drug Delivery Reviews, 61, 428–437. https://doi.org/10.1016/j.addr.2009.03.009

Dobrovolskaia, Marina A., & McNeil, Scott E. (2009). Immunological properties of engineered nanomaterials (pp. 278–287). https://doi.org/10.1142/9789814287005_0029

Dobrovolskaia, Marina A., Patri, Anil K., Zheng, Jiwen, Clogston, Jeffrey D., Ayub, Nader, Aggarwal, Parag, Neun, Barry W., Hall, Jennifer B., & McNeil, Scott E. (2009). Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine: Nanotechnology, Biology, and Medicine, 5, 106–117. https://doi.org/10.1016/j.nano.2008.08.001

Dobrovolskaia, Marina A., Aggarwal, Parag, Hall, Jennifer B., & McNeil, Scott E. (2008). Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. 5, 487–495. https://doi.org/10.1021/mp800032f

Dobrovolskaia, Marina A., Clogston, Jeffrey D., Neun, Barry W., Hall, Jennifer B., Patri, Anil K., & McNeil, Scott E. (2008). Method for analysis of nanoparticle hemolytic properties in vitro. Nano Letters, 8, 2180–2187. https://doi.org/10.1021/nl0805615

Dobrovolskaia, Marina A., & McNeil, Scott E. (2007). Immunological properties of engineered nanomaterials. Nature Nanotechnology, 2, 469–478. https://doi.org/10.1038/nnano.2007.223

Hall, Jennifer B., Dobrovolskaia, Marina A., Patri, Anil K., & McNeil, Scott E. (2007). Characterization of nanoparticles for therapeutics. Nanomedicine, 2, 789–803. https://doi.org/10.2217/17435889.2.6.789

Patri, Anil K., Dobrovoiskaia, Marina A., Stern, Stephan T., & McNeil, Scott E. (2006). Preclinical characterization of engineered nanoparticles intended for cancer therapeutics (pp. 105–137).

McNeil, Scott E. (2005). Nanotechnology for the biologist. Journal of Leukocyte Biology, 78, 585–594. https://doi.org/10.1189/jlb.0205074